Equities

Meditera Tibbi Malzeme Sanayi ve Ticaret AS

MEDTR.E:IST

Meditera Tibbi Malzeme Sanayi ve Ticaret AS

Actions
Health CareMedical Equipment and Services
  • Price (TRY)39.60
  • Today's Change1.10 / 2.86%
  • Shares traded796.94k
  • 1 Year change+12.50%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 16:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of TRY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments489600395
Total Receivables, Net366274138
Total Inventory31727867
Prepaid expenses60305.96
Other current assets, total122513
Total current assets1,2431,207618
Property, plant & equipment, net87254885
Goodwill, net------
Intangibles, net1.072.010.60
Long term investments621339.56
Note receivable - long term0.070.060.03
Other long term assets0----
Total assets2,1781,890719
LIABILITIES
Accounts payable23317770
Accrued expenses30185.63
Notes payable/short-term debt1700.32
Current portion long-term debt/capital leases302323
Other current liabilities, total172228
Total current liabilities328240127
Total long term debt52617.47
Total debt998531
Deferred income tax78607.78
Minority interest6.472.44--
Other liabilities, total18207.55
Total liabilities482383150
SHAREHOLDERS EQUITY
Common stock11911934
Additional paid-in capital426371177
Retained earnings (accumulated deficit)977915328
Treasury stock - common(70)0--
Unrealized gain (loss)21010130
Other equity, total341.260.43
Total equity1,6961,506569
Total liabilities & shareholders' equity2,1781,890719
Total common shares outstanding118119119
Treasury shares - common primary issue1.3200
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.